Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.
Excess mortality in middle-aged men with diabetes aged 15-34 years at diagnosis.
Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity.